Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2025 Earnings Call Transcript November 4, 2025
Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.01333.
Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2025 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Melissa Jarel, Executive...
